- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Swiss Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
2
1 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
2 companies
Novartis
Market Cap: CHF 190.5b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 98.40
7D
0.6%
1Y
0.5%
Xlife Sciences
Market Cap: CHF 115.4m
Focuses on the development and commercialization of research projects in the life sciences sector.
New
XLS
CHF 20.00
7D
5.3%
1Y
-40.1%